Overweight and Obesity in Saudi Patients with Schizophrenia Affects Cholesterol Concentration and Some Immune System Cells
Sawsan Hassan Mahassni, Razan Ahmed Alyoubi
Asian Journal of Immunology · pp. 106–119 · Published 9 Nov 2021
Abstract
Introduction: Schizophrenia (SZ), a prevalent and highly debilitating mental disease, is associated with high rates of overweight and obesity and effects on different systems of the body including the immune system. There are very few studies worldwide on weight measured by the body mass index (BMI) in patients with SZ and its effect on blood parameters, while there are no such studies in Saudi Arabia. Aims: This study is the first to determine the effects of weight, measured by the BMI, on the differential complete blood count in patients with SZ. Additionally, the serum lipid profile was determined. Methodology: Blood samples were collected from 45 randomly chosen male inpatients with SZ with an age range of 28-47 years and a mean age of 37 years. Results: BMI categorization of the patients showed that 6.7% were underweight, 53.3% were healthy, 24.4% were overweight, and 15.6% were obese. Compared with the healthy BMI, significantly lower cholesterol levels and neutrophil counts were found for the overweight BMI group, while significantly higher cholesterol levels and monocyte percents were found for the obese BMI group. Conclusion: Most subjects had a healthy BMI while overweight and obese subjects showed effects on cholesterol levels and counts of innate immune system cells.
Cited by 0
No indexed citations yet.
Related research
- Evaluation of Structural Changes in the Retina of Patients with Schizophrenia — shares topic coverage
- Antipsychotic Drugs Prescription Pattern among Patients with Schizophrenia in a Federal Neuropsychiatric Hospital Maiduguri, North East Nigeria — shares topic coverage
- Perceived Barriers to Help Seeking for Psychosis among Secondary School Students in Lagos, Nigeria — shares topic coverage
- Are Depot Anti-psychotics Associated with Longer Persistence in Treatment Compared with Oral Antipsychotics among Patients with Schizophrenia? — shares topic coverage
- Integrating Cognitive Behaviour Therapy into Schizophrenia Care — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.